Adverse Events Reported During Weekly Isoniazid-Rifapentine (3HP) Tuberculosis Preventive Treatment Among People With Human Immunodeficiency Virus in Uganda is a research paper published in Open Forum Infectious Diseases (2024). On theSindex it has a DataRank of 0.282. It has been cited 4 times, with 4 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
0.0405
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 4 citers.
National Institutes of Health
Grant: R01HL144406
National Institutes of Health
Grant: 7R01HL144406-06
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial
Fields of Study
Keywords